[go: up one dir, main page]

RU2016147400A - A method of treating cataracts and eye drops for its implementation - Google Patents

A method of treating cataracts and eye drops for its implementation Download PDF

Info

Publication number
RU2016147400A
RU2016147400A RU2016147400A RU2016147400A RU2016147400A RU 2016147400 A RU2016147400 A RU 2016147400A RU 2016147400 A RU2016147400 A RU 2016147400A RU 2016147400 A RU2016147400 A RU 2016147400A RU 2016147400 A RU2016147400 A RU 2016147400A
Authority
RU
Russia
Prior art keywords
methylethylpyridinol
eye drops
implementation
cataracts
treating cataracts
Prior art date
Application number
RU2016147400A
Other languages
Russian (ru)
Other versions
RU2016147400A3 (en
RU2662364C2 (en
Inventor
Павел Васильевич Смачков
Original Assignee
Общество с ограниченной ответственностью "ПРОФИТ ФАРМ"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество с ограниченной ответственностью "ПРОФИТ ФАРМ" filed Critical Общество с ограниченной ответственностью "ПРОФИТ ФАРМ"
Priority to RU2016147400A priority Critical patent/RU2662364C2/en
Publication of RU2016147400A3 publication Critical patent/RU2016147400A3/ru
Publication of RU2016147400A publication Critical patent/RU2016147400A/en
Application granted granted Critical
Publication of RU2662364C2 publication Critical patent/RU2662364C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Claims (2)

1. Способ лечения катаракты путем инстилляции лекарственного препарата в глаза, отличающийся тем, что инсталлируют глазные капли на основе метилэтилпиридинола по 1 и 2 капли 3 раза в день в течение 6 месяцев.1. A method of treating cataracts by instillation of a drug into the eyes, characterized in that they install eye drops based on methylethylpyridinol 1 and 2 drops 3 times a day for 6 months. 2. Глазные капли для лечения катаракты, включающие лекарственное средство на основе метилэтилпиридинола, отличающиеся тем, что в качестве действующего вещества используют метилэтилпиридинол (2-этил-6-метил-3-оксипиридина гидрохлорид) при следующем соотношении ингредиентов, г: метилэтилпиридинола гидрохлорид - 5,0-50,0 г; натрия сульфит безводный - 2,5 г; натрия бензоат - 2,0 г; калия дигидрофосфат - 5,4 г; натрия гидрофосфат додекагидрат - 6,5 г; метилцеллюлоза водорастворимая - 6,5 г; вода для инъекций - до 1 л.2. Eye drops for the treatment of cataracts, including a medicine based on methylethylpyridinol, characterized in that methylethylpyridinol (2-ethyl-6-methyl-3-hydroxypyridine hydrochloride) is used as the active ingredient in the following ratio of ingredients, g: methylethylpyridinol hydrochloride - 5 0-50.0 g; sodium sulfite anhydrous - 2.5 g; sodium benzoate - 2.0 g; potassium dihydrogen phosphate - 5.4 g; sodium hydrogen phosphate dodecahydrate - 6.5 g; water soluble methyl cellulose - 6.5 g; water for injection - up to 1 liter.
RU2016147400A 2016-12-02 2016-12-02 Method for cataract treatment and eye drops for implementation thereof RU2662364C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2016147400A RU2662364C2 (en) 2016-12-02 2016-12-02 Method for cataract treatment and eye drops for implementation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2016147400A RU2662364C2 (en) 2016-12-02 2016-12-02 Method for cataract treatment and eye drops for implementation thereof

Publications (3)

Publication Number Publication Date
RU2016147400A3 RU2016147400A3 (en) 2018-06-05
RU2016147400A true RU2016147400A (en) 2018-06-05
RU2662364C2 RU2662364C2 (en) 2018-07-25

Family

ID=62557380

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2016147400A RU2662364C2 (en) 2016-12-02 2016-12-02 Method for cataract treatment and eye drops for implementation thereof

Country Status (1)

Country Link
RU (1) RU2662364C2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2720676C2 (en) * 2019-07-22 2020-05-12 Надежда Витальевна Корсакова Eye drops for treating age-related nuclear cataract
RU2748598C1 (en) * 2020-09-15 2021-05-27 Надежда Витальевна Корсакова Improved eye drops for prevention and treatment of early manifestations of age-related nuclear cataract

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA62795U (en) * 2011-04-12 2011-09-12 Государственное Учреждение "Институт Глазных Болезней И Тканевой Терапии Им. В.П. Филатова Академии Медицинских Наук Украины" Method for preventing cataract in patients with keratitis
RU2533276C1 (en) * 2013-10-09 2014-11-20 Станислав Анатольевич Кедик Eye drops based on composition of pharmaceutically acceptable additive acid salts and methylethyl pyridonol and taurine containing composition of group b vitamins
RU2528912C1 (en) * 2013-10-09 2014-09-20 Станислав Анатольевич Кедик Eye drops based on pharmaceutically tolerable additive salts of acid and methyl ethyl encephabol containing composition of vitamins b
RU2585400C2 (en) * 2014-08-26 2016-05-27 Общество с ограниченной ответственностью "ФАРМАКТИВ" Dosage form based on butylaminohydroxypropoxyphenoxymethyl methyloxadiazole

Also Published As

Publication number Publication date
RU2016147400A3 (en) 2018-06-05
RU2662364C2 (en) 2018-07-25

Similar Documents

Publication Publication Date Title
EA202190115A1 (en) FILM FORMULATIONS CONTAINING DEXMEDETOMIDINE AND METHODS FOR THEIR PREPARATION
MX2020005217A (en) Ophthalmic composition and delivery device thereof.
WO2016172712A3 (en) Ophthalmic composition
EA201991299A1 (en) PREPARATION OF SOLID CYCLODEXTRIN COMPLEXES FOR DELIVERY OF OPHTHALMIC ACTIVE PHARMACEUTICAL INGREDIENTS
JOP20200031A1 (en) Methods for treating osteoarthritis with transdermal CBD gel
EA201790889A1 (en) OPHALMOLOGICAL SOLUTION
EP4279063A3 (en) Ophthalmic pharmaceutical composition, preparation method therefor and application thereof
MA48486B1 (en) Proton-binding polymers for oral administration
MX389336B (en) PHARMACEUTICAL FORMULATION.
HRP20240166T1 (en) Method of treating prader-willi syndrome
MY199237A (en) Methods of treating ocular conditions
MX2021007161A (en) AGENT CONTAINING URSODESOXYCOLIC ACID TO TREAT OR PREVENT PRESBYOPIA.
RU2016147400A (en) A method of treating cataracts and eye drops for its implementation
EA201600469A1 (en) PHARMACEUTICAL PREPARATION FOR PREVENTION AND TREATMENT OF PROGRESSIVE PATTERNS
BR112018008769A2 (en) pharmaceutical formulations, reconstituted and lyophilized aqueous liquid formulations, syringe, method of manufacturing a pharmaceutical formulation, method for treating a disease and use of a reconstructed formulation
EA201990550A1 (en) OPHTHALMIC DRUG INCLUDING THE ASOLIC COMPOUND
EA201690903A1 (en) TREATMENT GLAUCOMA USING LAQUINIMODE
MX2017015202A (en) Liquid formulations of celecoxib for oral administration.
WO2014204357A3 (en) Drug for the treatment of keratoconus
MX2025002392A (en) Dantrolene formulations and methods of their use
RU2015133365A (en) ALPHA-2 ADRENERGIC AGONIST FOR TREATMENT OF IN-EYE PRESSURE AND DISEASES OF THE EYES BY ADMINISTRATION IN A GLASS-BODY AND INTRACAMEROUS
RU2014148062A (en) INJECTION PHARMACEUTICAL COMPOSITION OF DEXKETOPROFEN AND TRAMADOL
RU2014117266A (en) OPHTHALMIC DRUG IN THE FORM OF EYE-DROPS ON THE BASIS OF N-ACETYL-HOMOTAURINE
RU2014106328A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING 4-BROM-N- (IMIDAZOLIDIN-2-YLIDENE) -1H-BENZIMIDAZOL-5-AMINE FOR THE TREATMENT OF RETAIL DISEASES
MX381515B (en) PHARMACEUTICAL COMPOSITION INCLUDING NEBIVOLOL WITH IMPROVED DISSOLUTION RATE